Literature DB >> 36065468

Diffusion-weighted imaging-positive lesions following endovascular treatment for ruptured and unruptured aneurysms: Its incidence according to antithrombotic drugs.

Sang Hyuk Lee1, Seung Hwan Kim1, Ji Hwan Jang1, Young Zoon Kim1, Kyu Hong Kim1, Taek Min Nam1.   

Abstract

OBJECTIVE: Microembolic infarcts are frequently observed on diffusion-weighted imaging (DWI) following endovascular treatment. We investigated DWI-positive lesions and symptomatic ischemic complications (SICs) in patients with ruptured and unruptured aneurysms following coiling and the relationship between DWI-positive lesions and antithrombotic drugs.
METHODS: Between January 2016 and December 2020, 83 patients underwent DWI within 48 h following endovascular treatment for ruptured (n=30) and unruptured (n=53) aneurysms.
RESULTS: The overall rate of DWI-positive lesions was 55.4%. There were no significant differences in the occurrence rate (45.3% vs. 43.3%, p=1.000) and the number of lesions (2.7±4.6 vs. 4.0±5.3, p=0.237) between unruptured and ruptured aneurysms. SIC occurred more frequently in patients with ruptured aneurysms than unruptured ones (20.0% vs. 1.9%, p=0.015). The cutoff value of DWI-positive lesions for predicting SIC was 5 (sensitivity 100%, specificity 78.9%). The procedure time was significantly longer in patients with DWI-positive lesions ≥5 than those with DWI-positive lesions <5 (104.1±43.8 vs. 85.1±30.8 min, p=0.030). Patients with DWI-positive lesions <5 were more frequently observed in the postprocedural heparinization group than in the no heparinization group (85.7% vs. 58.5%, p=0.012).
CONCLUSIONS: The incidence of DWI-positive lesions did not differ significantly between the ruptured and unruptured aneurysms. However, SIC occurred more frequently in patients with ruptured aneurysms. Longer procedure time is a risk factor for DWI-positive lesions, and postprocedural heparinization seems to reduce the incidence of DWI-positive lesions.

Entities:  

Keywords:  Antithrombotic drugs; Cerebral aneurysm; Diffusion-weighted imaging; Endovascular treatment; Heparinization

Year:  2022        PMID: 36065468      PMCID: PMC9537642          DOI: 10.7461/jcen.2022.E2022.01.002

Source DB:  PubMed          Journal:  J Cerebrovasc Endovasc Neurosurg        ISSN: 2234-8565


  26 in total

1.  Diffusion-weighted MRI in vascular dementia.

Authors:  S H Choi; D L Na; C S Chung; K H Lee; D G Na; J C Adair
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 2.  Diffusion-Weighted Imaging-Detected Ischemic Lesions following Endovascular Treatment of Cerebral Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  K M Bond; W Brinjikji; M H Murad; D F Kallmes; H J Cloft; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-17       Impact factor: 3.825

3.  Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes.

Authors:  Robert F James; Nicolas K Khattar; Zaid S Aljuboori; Paul S Page; Elaine Y Shao; Lacey M Carter; Kimberly S Meyer; Michael W Daniels; John Craycroft; John R Gaughen; M Imran Chaudry; Shesh N Rai; D Erik Everhart; J Marc Simard
Journal:  J Neurosurg       Date:  2018-05-11       Impact factor: 5.115

4.  Evaluation of ischemic lesion prevalence after endovascular treatment of intracranial aneurysms, as documented by 3-T diffusion-weighted imaging: a 2-year, single-center cohort study.

Authors:  Christina Iosif; Jean-Christophe Lecomte; Eduardo Pedrolo-Silveira; George Mendes; Marie-Paule Boncoeur Martel; Suzana Saleme; Charbel Mounayer
Journal:  J Neurosurg       Date:  2017-06-09       Impact factor: 5.115

5.  Microembolic signal monitoring after coiling of unruptured cerebral aneurysms: an observational analysis of 123 cases.

Authors:  G A Schubert; C Thomé; M Seiz; C Douville; J Eskridge
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-16       Impact factor: 3.825

6.  Microembolism after endovascular coiling of unruptured cerebral aneurysms: incidence and risk factors.

Authors:  Jung Cheol Park; Deok Hee Lee; Jae Kyun Kim; Jae Sung Ahn; Byung Duk Kwun; Dae Yoon Kim; Choong Gon Choi
Journal:  J Neurosurg       Date:  2015-09-18       Impact factor: 5.115

7.  Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage.

Authors:  Walter M van den Bergh; Richard S C Kerr; Ale Algra; Gabriel J E Rinkel; Andrew J Molyneux
Journal:  Stroke       Date:  2009-04-23       Impact factor: 7.914

8.  Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms.

Authors:  N K Yamada; D T Cross; T K Pilgram; C J Moran; C P Derdeyn; R G Dacey
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

9.  Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.

Authors:  J Marc Simard; E Francois Aldrich; David Schreibman; Robert F James; Adam Polifka; Narlin Beaty
Journal:  J Neurosurg       Date:  2013-09-13       Impact factor: 5.115

Review 10.  Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review.

Authors:  Sarah Mousavi; Mandana Moradi; Tina Khorshidahmad; Maryam Motamedi
Journal:  Adv Pharmacol Sci       Date:  2015-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.